CG
IART icon

Cutler Group’s Integra LifeSciences IART Stock Holding History

Cutler Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-4,723
Closed -$257K – 6206
2017
Q2 		$257K Buy
+4,723
New +$226K 0.01% 1091
2016
Q2 		– Sell
-550
Closed -$19.8K – 6909
2016
Q1 		$18K Buy
550
+366
+199% +$11.4K ﹤0.01% 3392
2015
Q4 		$6K Buy
+184
New +$5.75K ﹤0.01% 4704

Other funds holding IART

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EVM
Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cutler Group's IART Position: Q3 2017 in Review

Cutler Group sold out of Integra LifeSciences (IART) in Q3 2017, closing a stake of 4,723 shares — an estimated $257K sold.

Cutler Group first reported a position in IART in Q4 2015 and held it in 3 quarters. The position peaked at $257K in Q2 2017. 213 funds tracked by Wall St. Rank hold IART as of Q3 2017.

  • Cutler Group reported no remaining Integra LifeSciences position as of Q3 2017 after selling out during the quarter.
  • Cutler Group sold 4,723 Integra LifeSciences shares in Q3 2017, an estimated $257K.
  • Cutler Group first reported a position in Integra LifeSciences in Q4 2015 and held it in 3 quarters.
  • Cutler Group's Integra LifeSciences position peaked at $257K in Q2 2017.
  • 213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2017.

Based on Cutler Group's 13F filing for Q3 2017, filed 17 Oct 2017.